Correction To: Analysis of Autonomic Outcomes in Apollo, a Phase Iii Trial of the Rnai Therapeutic Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis (Journal of Neurology, (2019), 10.1007/S00415-019-09602-8)
AuthID
P-00R-QS7
P-00R-QS7